Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...

This clinical-stage biotech develops antibody therapies for thyroid eye disease, advancing multiple candidates through its R&D pipeline.

This biotechnology firm develops precision therapies for rare, genetically defined diseases, with a focus on targeted cancer treatments.

Cogent Biosciences develops targeted therapies for genetically defined diseases, focusing on precision medicine for rare ...

Researchers at Kenya’s Ol Pejeta Conservancy witnessed a biological breakthrough recently when a southern white rhinoceros ...

The biotechnology program launching this fall at the Omaha area's Metropolitan Community College was developed in partnership ...

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

Mayo Clinic in Arizona has two campuses. The largest is in north Phoenix, where a big expansion is underway. Here's what to ...

India's bioeconomy has expanded from about USD 10 billion in 2014 to more than USD 195 billion in 2025, reflecting a massive growth trajectory over the past decade, Union Minister Jitendra Singh said ...

India, March 21 -- Students from the Department of Biotechnology, Chandigarh College of Technology (CCT), Chandigarh Group of Colleges, Landran, demonstrated outstanding performance at the Tech ...

This week on "The Readout LOUD," a conversation with biotech "godfather" Stelios Papadapolous live from #STATBreakthrough.